Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment

INTRODUCTION: Cancer cells can achieve immune evasion by expressing the programmed death receptor 1 ligand (PD-L1) on the cell surface. Blockade of the receptor (PD-1) can avert this evasion. Here we aim at investigating PD-L1 expression in erlotinib-resistant lung cancer cells with MET proto-oncoge...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Demuth, Christina, Andersen, Morten Nørgaard, Jakobsen, Kristine Raaby, Madsen, Anne Tranberg, Sørensen, Boe Sandahl
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620250/
https://ncbi.nlm.nih.gov/pubmed/28978110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19920
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items